KING OF PRUSSIA, Pa., Oct. 29, 2024 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that Steve Filton, Executive Vice President and Chief Financial Officer will present at the 2024 Wolfe Research Healthcare Conference in New York, New York on Tuesday, November 19, 2024 at 12:20PM (ET).
A live audio webcast of the presentation will be available on the Company's website (www.uhsinc.com). For those unable to listen to the live webcast, replays of the presentation will be available on the Company's website for 90 days following the conference.
Universal Health Services, Inc. is one of the nation's largest hospital companies, operating through its subsidiaries, acute care hospitals, behavioral health facilities and ambulatory centers located throughout the United States, the United Kingdom, and Puerto Rico.
| Last Trade: | US$154.75 |
| Daily Change: | -20.05 -11.47 |
| Daily Volume: | 748,132 |
| Market Cap: | US$9.090B |
March 11, 2025 February 26, 2025 | |
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MORE
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORE
